ONCOCYTE CORP (OCX) Institutional Ownership Changes & 13F Activity

ONCOCYTE CORP (OCX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Broadwood Capital Inc, Awm Investment Company, Inc., Pura Vida Investments, Llc, Geode Capital Management, Llc, and Blackrock, Inc..

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Flatrock Wealth Partners LlcBuy+13,044—13,044$42.78KQ4 2025May 26, 2026
Broadwood Capital IncBuy+11,410,100—11,410,100$85.58MQ4 2025Feb 17, 2026
683 Capital Management, LlcBuy+77,204—77,204$579.03KQ4 2025Feb 17, 2026
Susquehanna International Group, LlpBuy+72,451—72,451$543.38KQ4 2025Feb 17, 2026
Millennium Management LlcBuy+61,377—61,377$460.33KQ4 2025Feb 17, 2026
Northern Trust CorpBuy+48,858—48,858$366.44KQ4 2025Feb 17, 2026
Qube Research & Technologies LtdBuy+28,351—28,351$212.63KQ4 2025Feb 17, 2026
Osaic Holdings, Inc.Buy+24,136—24,136$181.02KQ4 2025Feb 17, 2026
Citadel Advisors LlcBuy+15,647—15,647$117.35KQ4 2025Feb 17, 2026
Private Advisor Group, LlcBuy+10,416—10,416$78.12KQ4 2025Feb 17, 2026
Bank Of America CorpBuy+335—335$2.51KQ4 2025Feb 17, 2026
Tower Research Capital Llc (Trc)Buy+250—250$1.88KQ4 2025Feb 17, 2026
Awm Investment Company, Inc.Buy+2,814,230—2,814,230$21.11MQ4 2025Feb 13, 2026
Pura Vida Investments, LlcBuy+947,134—947,134$7.10MQ4 2025Feb 13, 2026
State Street CorpBuy+47,754—47,754$358.15KQ4 2025Feb 13, 2026
Morgan StanleyBuy+35,913—35,913$269.35KQ4 2025Feb 13, 2026
Omers Administration CorpBuy+26,164—26,164$196.23KQ4 2025Feb 13, 2026
Hudson Bay Capital Management LpBuy+13,061—13,061$97.96KQ4 2025Feb 13, 2026
Citigroup IncBuy+1—1$8.00Q4 2025Feb 13, 2026
Blackrock, Inc.Buy+131,361—131,361$985.21KQ4 2025Feb 12, 2026
Jane Street Group, LlcBuy+42,469—42,469$318.52KQ4 2025Feb 12, 2026
Renaissance Technologies LLCSell-10,200-43.2%13,400$100.50KQ4 2025Feb 12, 2026
Jpmorgan Chase & CoBuy+154—154$1.16KQ4 2025Feb 11, 2026
Goldman Sachs Group IncBuy+23,965—23,965$179.74KQ4 2025Feb 10, 2026
Bnp Paribas Financial MarketsBuy+30—30$225.00Q4 2025Feb 10, 2026
Geode Capital Management, LlcBuy+230,971—230,971$1.73MQ4 2025Feb 09, 2026
Eversource Wealth Advisors, LlcBuy+5,000—5,000$37.50KQ4 2025Feb 06, 2026
Sbi Securities Co., Ltd.Buy+185—185$1.39KQ4 2025Feb 03, 2026
Ubs Group AgBuy+2,941—2,941$22.06KQ4 2025Jan 29, 2026
Albion Financial GroupBuy+7—7$53.00Q4 2025Jan 21, 2026
Showing 30 of 32

Frequently asked questions about OCX activity

  • Which institutional owners are buying OCX?

    Institutional owners buying OCX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in OCX activity?

    "Buy" means an investor increased their reported position in OCX compared to the prior reporting period. This reflects growing exposure to ONCOCYTE CORP (OCX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in OCX increasing?

    Institutional interest in OCX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.